This anti-tumor activity is closely associated with the increase of tumor-specific T cells, the enhancement of CD4 + T cells and CD8 + T cell infiltration and the significant decrease of tumor resident CD4 + CCR8 + Treg. The gene discussed is CD4; the disease is neoplasm.